Long Term Results Comparing Mechanical and Biological Prostheses in the Tricuspid Valve Position

Songur, Çetin Murat; Simsek, Erdal; Özen, Anıl; Kocabeyoğlu, Sınan Sabit; Donmez, Tugba Avcı

doi:10.1016/j.hlc.2014.05.015

Cited by 35 publications

(35 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based on our literature research strategy, 26 studies were identified, all of which were retrospective. Among these studies, the series of Rizzoli and colleagues, van Nooten and colleagues, Do and colleagues, and Hwang and colleagues were replicated in two different papers and the duplicated data were excluded to avoid estimation bias .…”

Section: Resultsmentioning

confidence: 99%

“…Among these studies, the series of Rizzoli and colleagues, van Nooten and colleagues, Do and colleagues, and Hwang and colleagues were replicated in two different papers and the duplicated data were excluded to avoid estimation bias . Thus, 22 studies were further analyzed and the characteristics of the individual studies are summarized in Table . These studies included 2630 individuals with an approximate mean age of 48.7 years, and the ratio of male to female was 0.43.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The choice between using biological or mechanical prosthesis in the tricuspid position should be made on an individual basis according to clinical judgment (11). The advantage of the bioprosthesis is that it does not require long life anticoagulation therapy and is associated with a low risk of hemorrhage with increasing age (12).…”

Section: Discussionmentioning

confidence: 99%

The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation

Liang¹

2019

Anatol J Cardiol

View full text Add to dashboard Cite

The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation Introduction Primary tricuspid valve regurgitation is rarely observed in adults and is known to result from congenital heart disease, rheumatic heart disease, myxomatous valve disease, infective endocarditis, carcinoid syndrome, and/or infiltrative valvulopathy (1). Tricuspid valve repair is the first option for patients with primary or secondary tricuspid regurgitation. However, valve replacement, instead of repair, may be better for those with severe structural valve dysfunction. In patients with isolated tricuspid valve regurgitation, tricuspid valve replacement (TVR) has been associated with a considerable reported risk of mortality and a high incidence of prosthesis-related complications, which could lead to a high number of reoperations (2). With regard to prosthesis, the choice between mechanical and bioprosthetic valves remains controversial. Furthermore, only a few studies have assessed the clinical outcomes of patients with primary tricuspid valve regurgitation after isolated TVR. The aim of the present study was to evaluate the long-term outcomes in patients undergoing first-time TVR with a mechanical or bioprosthetic valve for severe isolated tricuspid valve regurgitation. Methods Patients A total of 98 patients with primary tricuspid valve regurgitation underwent first-time TVR at the West China Hospital in China between January 2010 and March 2017. The prosthesis used was determined by the attending physician after considering age, symptoms, other comorbidities, and particularly the will of the patients. The present study was Objective: The ideal alternative for tricuspid valve replacement (TVR) in patients with severe isolated tricuspid regurgitation remains unclear. The aim of the present study was to retrospectively investigate the outcomes of using bioprosthetic and mechanical valves at the tricuspid position. Methods: A total of 98 consecutive patients without left-side cardiac disease or history of heart surgery who underwent first-time TVR between January 2010 and March 2017 at the West China Hospital, China were included in the study. Patient data, including all-cause death and need for tricuspid valve reoperation as the main end points, were retrospectively evaluated. Results: A total of 76 patients were enrolled into the study. The mean follow-up period was 43.3±21.9 (10-87) months. The mean age of the patients was 45.7±13.4 years. The study comprised 32.9% of male patients. During the follow-up period, 4, 3, 12, and 3 cases of death, reoperation, prosthesis dysfunctions, and prosthesis-related thrombosis were noted, respectively. Biological and mechanical valves were used in 56.6% and 43.4% of the patients, respectively. However, there was no significant difference between mechanical and biological valves with respect to echocardiographic date and survival, reoperation, prosthetic valve dysfunction, and thromboembolism rate. Conclusion: TVR is not a very high-risk procedure in pa...

show abstract

“…Echocardiography revealed tricuspid stenosis with regurgitation, mild pulmonary artery hypertension and Right heart failure ( Figure 1). At the multidisciplinary meeting, further evaluation by Cardiology and Cardiothoracic Surgery regarding the status of pulmonary artery hypertension and the feasibility of tricuspid valve replacement (TVR) was discussed as TVR is a rarely performed procedure with operative mortality in the range of 14% to 17% [1,2]. Further, the risk of TVR in the presence of Carcinoid syndrome was discussed.…”

Section: Clinical Reportmentioning

confidence: 99%

A Case of Carcinoid Syndrome with Carcinoid Valvular Heart Disease Treated Successfully

Rajan¹,

Rajshekharan²,

Devi³

et al. 2017

J Clin Gastroenterol Hepatol

View full text Add to dashboard Cite

A 39-year-old lady presented in early 2011 with Carcinoid syndrome due to Ileal Carcinoid with liver metastases and Carcinoid valvular heart disease with Right heart failure. Liver resection combined with ethanol injection of Liver metastases was carried out after reduction of Central Venous Pressure by an initial Tricuspid valve replacement (TVR), in a staged manner, with resolution of symptoms. This case highlights the necessity of TVR prior to major Liver resection for Liver metastases in Carcinoid heart disease with Tricuspid regurgitation as well as the value of treating Carcinoid heart disease aggressively.Key words: Carcinoid heart disease; Tricuspid valve replacement; Liver resection. Clinical ReportA 39-year-old lady presented in early 2011 with history of postprandial flushing attacks of 6 years duration, pedal oedema and puffiness of face with persistent dry cough of 2 months duration. Elevated Jugular Venous Pressure (JVP), bilateral pitting pedal oedema and nontender hepatomegaly were noted on clinical examination. Ultrasound abdomen showed an 8 × 8 cm mass lesion with mixed echogenicity in the Left lobe, liver. Contrast Enhanced Computerized Tomography (CECT) of abdomen revealed a mixed density mass lesion with irregular contrast enhancement in the Left lobe of liver with multiple enhancing lesions in the right lobe, liver as well as an enhancing lesion in the terminal ileum. Carcinoid syndrome due to Ileal carcinoid with liver metastases and carcinoid valvular heart disease with right heart failure was diagnosed. 24 hours urinary 5 hydroxy indole acetic acid (24 hr urinary 5HIAA) estimation showed a very high value of 153 mg/day. Echocardiography revealed tricuspid stenosis with regurgitation, mild pulmonary artery hypertension and Right heart failure (Figure 1). At the multidisciplinary meeting, further evaluation by Cardiology and Cardiothoracic Surgery regarding the status of pulmonary artery hypertension and the feasibility of tricuspid valve replacement (TVR) was discussed as TVR is a rarely performed procedure with operative mortality in the range of 14% to 17% [1,2]. Further, the risk of TVR in the presence of Carcinoid syndrome was discussed. After detailed evaluation, it was decided to suggest TVR considering the favorable tumor biology and the fact that the resultant drop in Central Venous Pressure (CVP) would make way for a safe liver resection. It is well known that liver resection in the presence of high CVP carries higher morbidity and mortality [3].However, the relatives wanted time to think over, arrange finances and take a decision on the treatment plan. She was maintained on monthly Depot Octreotide. Meanwhile as she developed persistent pain in the lower abdomen with features of subacute bowel obstruction within a couple of months, a palliative resection of the primary in the ileum was carried out under regional anesthesia.

show abstract

Long Term Results Comparing Mechanical and Biological Prostheses in the Tricuspid Valve Position

Cited by 35 publications

References 21 publications

Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis

Should a Mechanical or Biological Prosthesis Be Used for a Tricuspid Valve Replacement? A Meta-Analysis

The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation

A Case of Carcinoid Syndrome with Carcinoid Valvular Heart Disease Treated Successfully

Contact Info

Product

Resources

About